E-DRUG: Applications for 2021 update of the WHO Model Lists of Essential Medicines
----------------------------------------------------------------------------
We are pleased to announce that applications for inclusion in the next revision of the WHO Model Lists of Essential Medicines have been published here
<https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/23rd-expert-committee>
and are open for public review and comment.
The meeting of the 23rd WHO Expert Committee on the Selection and Use of Essential Medicines will be coordinated from WHO Headquarters, Geneva and held virtually on 21 June to 2 July 2021 to revise and update the WHO Model List of Essential Medicines (EML) and the WHO Model List of Essential Medicines for Children (EMLc). During the meeting the Expert Committee will consider the applications along with accompanying comments.
The Secretariat welcomes comments that offer their perspective on the applications that includes additional evidence of: clinical efficacy and safety, public health relevance, consideration of cost and cost effectiveness, feasibility of implementation, and relevant perspectives from a country experience. Where relevant, data sources should be appropriately referenced.
Interested stakeholders are invited to submit comments on the applications to the Secretary of the Expert Committee, Dr Benedikt Huttner, via email to:
emlsecretariat@who.int
Comments must be provided in PDF format, and the file name should clearly reference the application to which they apply. All comments received will be published on this webpage and will be provided to the Expert Committee for their consideration. The deadline for submission of comments is 21 May 2021.
With thanks,
Bernadette Cappello
Technical Officer, WHO Essential Medicines Team
"CAPPELLO, Bernadette" <cappellob@who.int>